Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Health Service Policy

Breast cancer drug approved for NHS England

The drug trastuzumab emtansine (Kadcyla) will soon be routinely available for patients in England with an advanced type of breast cancer.

General Election 2017: What are the political parties promising for cancer and research?

A week away from the general election, we’ve put some of the manifestos under the microscope to see what they mean for cancer, research and patients.

General Election 2017: 4 things we want political parties to focus on

We look at the most important areas that parties need to focus on to tackle cancer ahead of the General Election.

NHS England sets target of 5,000 more people each year surviving cancer

NHS England aims for an extra 5,000 people each year to survive cancer by 2019, a new report claims.

'Unacceptable' plans revealed by NICE that could delay availability of drugs on the NHS in England

Plans to create an additional affordability test for medicines available on the NHS have been labelled ‘unacceptable’ by charities and politicians.

Budget 2017: Investment in social care and training young scientists

Additional funding for social care and investment in new research training placements have been announced in the Spring Budget.

A one-off bowel scope helps prevent bowel cancer, but it’s taking time to reach everyone eligible

A one-off screening test can cut bowel cancer risk for at least 17 years.

NHS cancer treatment target in England missed for third consecutive year

The ’62 day’ waiting time target for cancer patients in England has been missed again, marking 3 years since the target was last met.

7 tweets that defined cancer policy in 2016

We pick out 7 top stories from the world of cancer policy and politics that defined 2016.

Breast cancer drug currently too expensive for NHS

NICE has published draft guidance stating that the breast cancer drug trastuzumab emtansine (also known as Kadcyla) won't be routinely available through the NHS

Pages